Synlogic
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat ...
Synlogic Logo
About Synlogic
Synlogic, Inc. operates as a pharmaceutical company. The Company develops synthetic biotic medicines for inflammatory bowel diseases, cancer, metabolic diabetes, obesity, metabolic conditions, urea cycle disorders, and other rare genetic disorders. Synlogic serves customers in the United States.
Address
301 Binney Street, Suite 402
Cambridge, 02142
United States
Year founded
2014
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
